Related Articles
Immunological status of peripheral blood is associated with prognosis in patients with bone and soft-tissue sarcoma
Evaluation of immune‑biomarker expression in high‑grade soft‑tissue sarcoma: HLA‑DQA1 expression as a prognostic marker
Role of high‑sensitivity C‑reactive protein in patients with sarcoma
C‑reactive protein and related predictors in soft tissue sarcoma (Review)
Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line